United Arab Emirates (UAE) Immunology Market (2025-2031) Outlook | Analysis, Industry, Value, Trends, Revenue, Forecast, Companies, Size, Growth & Share

Market Forecast By Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And Competitive Landscape
Product Code: ETC328900 Publication Date: Aug 2022 Updated Date: Feb 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

UAE Immunology Market Synopsis

The UAE Immunology Market encompasses diagnostics, treatments, and research related to the immune system and its disorders. It is a critical component of the healthcare sector, addressing conditions such as autoimmune diseases and immunodeficiency disorders. The market is driven by advancements in medical science and the need for effective immunological therapies.

Drivers of the Market Outlook

The UAE Immunology market is experiencing growth due to several factors. Increasing incidence of autoimmune diseases and allergies necessitates immunology-related treatments and medications. Advancements in biotechnology and immunotherapy have led to the development of innovative treatments, fostering market expansion. Additionally, rising healthcare expenditure and government initiatives to improve healthcare infrastructure contribute to the market`s growth.

Challenges of the Market Outlook

The UAE Immunology market faces hurdles related to the high cost of advanced immunotherapies and biologics. Balancing affordability with the imperative for cutting-edge treatments poses a complex challenge for healthcare stakeholders. Furthermore, the market contends with evolving disease profiles, necessitating constant adaptation of treatment strategies. Access to specialized immunology care in remote or underserved areas presents an ongoing challenge, requiring innovative solutions for equitable healthcare delivery.

COVID-19 Impact on the Market Outlook

The COVID-19 pandemic had a profound impact on the UAE Immunology market. While the demand for immunology-related treatments remained steady, there was a shift in healthcare priorities towards addressing the immediate crisis. Routine immunology screenings and treatments faced delays and disruptions, leading to concerns about managing chronic conditions. The market also saw fluctuations in the availability of certain immunology drugs due to supply chain challenges. However, the pandemic accelerated the adoption of telemedicine and remote monitoring solutions, which are likely to reshape how immunology care is delivered in the UAE. As the healthcare system adapts and stabilizes, the market is expected to regain momentum.

Key Players in the Market Outlook

The UAE Immunology market is crucial for addressing autoimmune diseases and immune system disorders. Leading pharmaceutical companies in this field include AbbVie, Bristol-Myers Squibb, and Roche. They offer a range of biologic and immunosuppressive medications to manage these conditions.

Key Highlights of the Report:

  • United Arab Emirates (UAE) Immunology Market Outlook
  • Market Size of United Arab Emirates (UAE) Immunology Market, 2024
  • Forecast of United Arab Emirates (UAE) Immunology Market, 2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Revenues & Volume for the Period 2021-2031
  • United Arab Emirates (UAE) Immunology Market Trend Evolution
  • United Arab Emirates (UAE) Immunology Market Drivers and Challenges
  • United Arab Emirates (UAE) Immunology Price Trends
  • United Arab Emirates (UAE) Immunology Porter's Five Forces
  • United Arab Emirates (UAE) Immunology Industry Life Cycle
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Drug Class for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Monoclonal Antibody (mAb) for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Fusion Proteins for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Immunosuppressants for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Polyclonal Antibody (pAb) for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Others for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Disease Indication for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Rheumatoid Arthritis for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Psoriatic Arthritis for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Plaque Psoriasis for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Ankylosing Spondylitis for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Inflammatory Bowel Disease for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Prophylaxis of Organ Rejection for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Others for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Distribution Channel for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Hospital Pharmacies for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Retail Pharmacies for the Period 2021-2031
  • Historical Data and Forecast of United Arab Emirates (UAE) Immunology Market Revenues & Volume By Online Pharmacies for the Period 2021-2031
  • United Arab Emirates (UAE) Immunology Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Disease Indication
  • Market Opportunity Assessment By Distribution Channel
  • United Arab Emirates (UAE) Immunology Top Companies Market Share
  • United Arab Emirates (UAE) Immunology Competitive Benchmarking By Technical and Operational Parameters
  • United Arab Emirates (UAE) Immunology Company Profiles
  • United Arab Emirates (UAE) Immunology Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Arab Emirates (UAE) Immunology Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Arab Emirates (UAE) Immunology Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Arab Emirates (UAE) Immunology Market Overview

3.1 United Arab Emirates (UAE) Country Macro Economic Indicators

3.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, 2021 & 2031F

3.3 United Arab Emirates (UAE) Immunology Market - Industry Life Cycle

3.4 United Arab Emirates (UAE) Immunology Market - Porter's Five Forces

3.5 United Arab Emirates (UAE) Immunology Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United Arab Emirates (UAE) Immunology Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 United Arab Emirates (UAE) Immunology Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United Arab Emirates (UAE) Immunology Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United Arab Emirates (UAE) Immunology Market Trends

6 United Arab Emirates (UAE) Immunology Market, By Types

6.1 United Arab Emirates (UAE) Immunology Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Drug Class, 2021-2031F

6.1.3 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Monoclonal Antibody (mAb), 2021-2031F

6.1.4 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Fusion Proteins, 2021-2031F

6.1.5 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Immunosuppressants, 2021-2031F

6.1.6 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Polyclonal Antibody (pAb), 2021-2031F

6.1.7 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Others, 2021-2031F

6.2 United Arab Emirates (UAE) Immunology Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Rheumatoid Arthritis, 2021-2031F

6.2.3 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Psoriatic Arthritis, 2021-2031F

6.2.4 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Plaque Psoriasis, 2021-2031F

6.2.5 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Ankylosing Spondylitis, 2021-2031F

6.2.6 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Inflammatory Bowel Disease, 2021-2031F

6.2.7 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Prophylaxis of Organ Rejection, 2021-2031F

6.3 United Arab Emirates (UAE) Immunology Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F

6.3.3 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Retail Pharmacies, 2021-2031F

6.3.4 United Arab Emirates (UAE) Immunology Market Revenues & Volume, By Online Pharmacies, 2021-2031F

7 United Arab Emirates (UAE) Immunology Market Import-Export Trade Statistics

7.1 United Arab Emirates (UAE) Immunology Market Export to Major Countries

7.2 United Arab Emirates (UAE) Immunology Market Imports from Major Countries

8 United Arab Emirates (UAE) Immunology Market Key Performance Indicators

9 United Arab Emirates (UAE) Immunology Market - Opportunity Assessment

9.1 United Arab Emirates (UAE) Immunology Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United Arab Emirates (UAE) Immunology Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 United Arab Emirates (UAE) Immunology Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United Arab Emirates (UAE) Immunology Market - Competitive Landscape

10.1 United Arab Emirates (UAE) Immunology Market Revenue Share, By Companies, 2024

10.2 United Arab Emirates (UAE) Immunology Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All